Science News

Moderna's mRNA Flu Vaccine: A New Era for Flu Season

August 7, 2026Pablo Navarro1 мин

The introduction of Moderna's mFlusiva, the first mRNA flu vaccine, could significantly alter the landscape of flu season. Data suggests that this novel vaccine offers superior protection when compared to conventional flu shots. It has demonstrated the ability to stimulate a more robust and enduring immune response, leading to increased effectiveness in preventing flu infections.